What is Digirad?
Digirad Corporation operates as a multifaceted healthcare services provider, specializing in diagnostic imaging and medical device sales. The company's operational framework is divided into four distinct segments: Diagnostic Services, Mobile Healthcare, Diagnostic Imaging, and Medical Device Sales and Services. Through these divisions, Digirad delivers essential nuclear and ultrasound imaging capabilities, alongside comprehensive mobile diagnostic services including CT, MRI, and PET/CT scans. By integrating both hardware sales—often in partnership with major industry players like Philips—and service-based diagnostic support, the company occupies a unique niche in the healthcare ecosystem. Its ability to provide both on-site equipment and remote cardiac monitoring services allows it to serve a broad spectrum of clinical environments, from small physician offices to large-scale federal institutions.
How much funding has Digirad raised?
Digirad has raised a total of $93M across 3 funding rounds:
Stock Offering
$66M
Debt
$25M
Debt
$2M
Stock Issuance/Offering (2004): $66M, investors not publicly disclosed
Debt (2017): $25M led by Comerica Incorporated
Debt (2020): $2M supported by PPP
Key Investors in Digirad
Comerica Incorporated
Comerica Incorporated is a prominent financial services organization providing a range of banking and wealth management solutions, often acting as a strategic debt provider for established corporate entities.
PPP
Public-Private Partnership
Undisclosed Investor
An undisclosed investor participating in the historical equity financing rounds to support the company's initial growth and market entry.
What's next for Digirad?
Looking ahead, Digirad is poised to leverage its recent capital allocation to further optimize its service delivery and technological capabilities. Given the current market demand for efficient, mobile-first diagnostic solutions, the company is likely to prioritize the modernization of its imaging fleet and the expansion of its remote monitoring infrastructure. The strategic use of debt financing suggests a focus on operational scalability and the strengthening of its balance sheet to withstand the cyclical nature of medical device procurement. As the healthcare sector continues to emphasize value-based care, Digirad's ability to provide flexible, contract-based diagnostic services will be a key driver of its long-term growth and competitive differentiation in the domestic market.
See full Digirad company page
